Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$839M |
| 2 |
Amazon
AMZN
|
+$810M |
| 3 |
Tesla
TSLA
|
+$644M |
| 4 |
TSMC
TSM
|
+$546M |
| 5 |
Johnson & Johnson
JNJ
|
+$389M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$891M |
| 2 |
Home Depot
HD
|
+$441M |
| 3 |
JPMorgan Chase
JPM
|
+$335M |
| 4 |
NVO
Novo Nordisk
NVO
|
+$317M |
| 5 |
ASML
ASML
|
+$315M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.84% |
| 2 | Technology | 15.57% |
| 3 | Consumer Discretionary | 11.88% |
| 4 | Consumer Staples | 10.09% |
| 5 | Financials | 9.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
OLO
2401
DELISTED
Olo Inc
OLO
| $1.24M | ﹤0.01% |
198,100
-80,600
| -29% | -$608K |
|
2402
State Street SPDR Portfolio S&P 600 Small Cap ETF
SPSM
$17.7B
| $1.24M | ﹤0.01% |
33,500
+18,200
| +119% | +$682K |
|
2403
Bright Horizons
BFAM
$3.75B
| $1.24M | ﹤0.01% |
19,600
+11,500
| +142% | +$753K |
|
2404
Capital Group International Focus Equity ETF
CGXU
$6.63B
| $1.24M | ﹤0.01% |
59,300
+46,772
| +373% | +$957K |
|
|
PHX
2405
DELISTED
PHX Minerals
PHX
| $1.23M | ﹤0.01% |
316,900
-107,600
| -25% | -$404K |
|
|
ABST
2406
DELISTED
Absolute Software Corp
ABST
| $1.23M | ﹤0.01% |
117,800
-20,000
| -15% | -$209K |
|
2407
Consensus Cloud Solutions
CCSI
$716M
| $1.23M | ﹤0.01% |
22,800
-1,700
| -7% | -$92.6K |
|
|
ATXS
2408
DELISTED
Astria Therapeutics
ATXS
| $1.23M | ﹤0.01% |
82,261
+24,400
| +42% | +$252K |
|
2409
Riskified
RSKD
$875M
| $1.22M | ﹤0.01% |
264,700
-79,800
| -23% | -$372K |
|
2410
PIMCO 1-5 Year US TIPS Index Exchange-Traded Fund
STPZ
$525M
| $1.22M | ﹤0.01% |
24,517
-34,983
| -59% | -$1.75M |
|
|
EXPR
2411
DELISTED
Express, Inc.
EXPR
| $1.22M | ﹤0.01% |
59,945
-48,527
| -45% | -$1.16M |
|
|
MCHB
2412
Mechanics Bancorp
MCHB
$3.78B
| $1.22M | ﹤0.01% |
44,300
-11,800
| -21% | -$323K |
|
|
CMRX
2413
DELISTED
Chimerix, Inc.
CMRX
| $1.22M | ﹤0.01% |
656,795
+193,686
| +42% | +$379K |
|
2414
Eagle Bancorp Montana
EBMT
$187M
| $1.22M | ﹤0.01% |
75,410
-9,200
| -11% | -$167K |
|
2415
AZZ Inc
AZZ
$4.55B
| $1.22M | ﹤0.01% |
30,281
-104,819
| -78% | -$4.12M |
|
2416
iShares MSCI Pacific ex Japan ETF
EPP
$2.24B
| $1.22M | ﹤0.01% |
28,400
-37,300
| -57% | -$1.53M |
|
2417
Galicia Financial Group
GGAL
$6.97B
| $1.21M | ﹤0.01% |
124,700
+48,550
| +64% | +$383K |
|
2418
Hydrofarm Holdings
HYFM
$7M
| $1.21M | ﹤0.01% |
78,110
+3,789
| +5% | +$86.6K |
|
2419
BancFirst
BANF
$3.89B
| $1.21M | ﹤0.01% |
13,691
-32,497
| -70% | -$3.07M |
|
|
ADN
2420
DELISTED
Advent Technologies
ADN
| $1.21M | ﹤0.01% |
22,210
+10,367
| +88% | +$642K |
|
2421
Eversource Energy
ES
$27.2B
| $1.21M | ﹤0.01% |
14,380
-455,900
| -97% | -$36.2M |
|
2422
Mastech Digital
MHH
$94.7M
| $1.2M | ﹤0.01% |
109,227
+6,600
| +6% | +$91.7K |
|
2423
Vanguard Long-Term Treasury ETF
VGLT
$10.3B
| $1.2M | ﹤0.01% |
19,500
-18,900
| -49% | -$1.17M |
|
2424
iShares Core Dividend Growth ETF
DGRO
$43.8B
| $1.2M | ﹤0.01% |
24,000
+10,500
| +78% | +$515K |
|
2425
Rigel Pharmaceuticals
RIGL
$795M
| $1.2M | ﹤0.01% |
79,850
-50,673
| -39% | -$465K |
|
Similar funds
Jim Simons's Q4 2022 Portfolio in Review
As of Q4 2022, Jim Simons held 4,601 positions worth $73.1B, up 3.4% from $70.7B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons's Q4 2022 filing shows 626 new, 1,390 increased, 2,018 reduced and 522 closed positions. Its largest new stake was Johnson & Johnson: 2,254,125 shares worth $398M. The largest sale was Microsoft, an estimated $891M.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jim Simons's largest Q4 2022 buy was Johnson & Johnson: 2,254,125 shares worth $398M.
- Jim Simons added most to Apple in Q4 2022, an estimated $839M increase.
- Jim Simons's biggest Q4 2022 reduction was Novo Nordisk, cutting an estimated $317M.
- Jim Simons fully exited Microsoft in Q4 2022, selling an estimated $891M.
- Jim Simons's ten largest holdings make up 11% of its $73.1B portfolio in Q4 2022.
- Jim Simons opened 626 new positions and closed 522 in Q4 2022.
- Jim Simons's portfolio value rose 3.4% quarter-over-quarter to $73.1B.
Based on Renaissance Technologies's 13F filing for Q4 2022, filed 13 Feb 2023.